A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Han, BH; Li, K; Zhao, YZ; Wang, QM; Zhang, L; Shi, JH; Wang, ZH; He, JX; Shi, YK; Cheng, Y; Chen, WQ; Wang, XW; Luo, Y; Nan, KJ; Jin, FG; Dong, J; Li, BL; Zhou, JY; Chen, YL; Wang, DL; Zhou, X; Yu, Y; Chen, LM; Liu, AW; Huang, JJ; Huang, C; Cao, BW;

JOURNAL OF THORACIC ONCOLOGY, 2017; 12 (1): S886